GENENTECH COULD BE FLUSH WITH $700 MIL. CASH, SWISS BANKER, AND LESS ACCOUNTABILITY TO FINICKY WALL STREET; ROCHE OFFERS $2.1 BIL. FOR CONTROL

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".